Merck, Ridgeback to supply 3 million courses of molnupiravir

Merck and Ridgeback Biotherapeutics will sign a “long-term supply agreement” with the United Nations Children’s Fund (UNICEF) to ensure global access to molnupiravir, the COVID-19 oral…